RILYZ (RILYZ) Stock Price & Analysis
RILYZ (RILYZ) fell 0.26% to USD 19 as of July 25, 2026 at 15:04 UTC, according to Nexqual real-time market data.
RILYZ last closed at USD 19.05; the session ranged USD 18.95–19.04 on volume of 28,313 shares. Market capitalization is —, with a 52-week range of USD 8.65–20.6 (NGM). Source: Nexqual, July 25, 2026 at 15:04 UTC.
Key Statistics (as of July 25, 2026 at 15:04 UTC)
| Price | USD 19 |
|---|---|
| Change | ▼ 0.26% (down) |
| Previous Close | USD 19.05 |
| Open | USD 18.97 |
| Day Range | USD 18.95 – 19.04 |
| 52-Week Range | USD 8.65 – 20.6 |
| Volume | 28,313 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RILYZ)
Nexqual's technical model rates RILYZ "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 15:04 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.52 (neutral) |
| vs SMA50 | Below (USD 19.35) |
| MACD | -0.02 (negative) |
Earnings (RILYZ)
Source: Nexqual, July 25, 2026 at 15:04 UTC.
Financial Health Score (RILYZ)
Nexqual rates RILYZ's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 15:04 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
From RILYZ's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RILYG | BRC Group Holdings, Inc. - 5.00 | USD 24.4 | ▼ 0.19% |
| RILYN | BRC Group Holdings, Inc. - 6.50 | USD 24.84 | ▲ 0.32% |
| RILYT | BRC Group Holdings, Inc. - 6.00 | USD 20.07 | ▲ 0.25% |
| RILYL | BRC Group Holdings, Inc. - Depo | USD 13.8 | ▼ 1.08% |
| RILYP | BRC Group Holdings, Inc. - Depo | USD 13.42 | ▼ 1.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:04 UTC. This page is informational and not investment advice.